JAK inhibition offers promising treatment prospects for uncommon dermatoses Presented ByProf. Matthew Vesely, Yale School of Medicine, USA ConferenceAAD 2022 TypePeer-reviewed article 17 May 2022 11:48
Potential biomarker discovered for treatment response to ustekinumab Presented ByMr Shane Solanky, King’s College London, UK ConferencePFGC 2021 TypePeer-reviewed article 3 February 2022 15:46